Here’s another one of those “Let’s lift a bunch of material from the company we work for and start our own!” schemes:
According to the indictment, Yu Xue and Lucy Xi were scientists working at GSK’s research facility in Upper Merion, Pa., when they engaged in an alleged scheme to steal trade secrets related to GSK research data, procedures, and manufacturing processes for biopharmaceutical products. Many of the biopharmaceutical products they allegedly targeted were designed to treat cancer or other serious diseases.
Yu Xue, Tao Li, and Yan Mei allegedly formed a corporation in China, called Renopharma, to market and sell the trade secret information. The indictment further alleged that in order to hide the proceeds of the crime, Yu Xue, Tao Li, and Yan Mei agreed to title the proceeds in the name of Yu Xue’s sister, Tian Xue, and other family members.
I suppose there’s no good way of knowing if any of these plans ever work, but there are numerous examples of ones that haven’t. Some of this is done one a larger scale, too, of course (discussion here). My guess is that the bigger ones tend to bring a worthwhile return to those sponsoring them, while the smaller enterpreneurs tend to end up talking to the FBI, but I have no data to back that up.